64/100BMedline P/E ratioWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
Medline's P/E ratio is 58.87: its share price of 39.44 over its earnings per share of 0.67 over the last twelve months.
- Today
- 58.87
- Forward P/E, next 12 months
- 25.44
- PEG ratio
- 8.13
- Average, 5 years
- 35.38
- Low, 5 years
- 26.87
- High, 5 years
- 62.93
P/E ratio = price ÷ EPS (last 12 months) = 39.44 ÷ 0.67 = 58.87
Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.
The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.
P/E ratio by year and by quarter
| Fiscal year | Period ending | P/E ratio | Forward P/E | Market cap | Net income |
|---|---|---|---|---|---|
| FY2026 · Estimate | 31 Dec 2026 | 25.58 | — | — | — |
| FY2025 · Estimate | 31 Dec 2025 | 32.79 | — | — | — |
| Today | 58.87 | 25.44 | 34.65B | 876.00M | |
| FY2025 | 31 Dec 2025 | 29.43 | 27.22 | 34.10B | 1.16B |
| FY2024 | 31 Dec 2024 | 26.89 | — | 32.27B | 1.20B |
| FY2023 | 31 Dec 2023 | 137.91 | — | 32.27B | 234.00M |
| FY2022 | 31 Dec 2022 | — | — | 32.27B | -25.00M |
| Quarter | Period ending | P/E ratio | Forward P/E | Market cap | Net income |
|---|---|---|---|---|---|
| Q3 FY2026 | 26 Sept 2026 | 34.72 | 22.40 | 30.41B | 876.00M |
| Q2 FY2026 | 27 Jun 2026 | 43.26 | 25.11 | 33.31B | 770.00M |
| Q1 FY2026 | 31 Mar 2026 | 37.81 | 28.81 | 36.45B | 964.00M |
| Q4 FY2025 | 31 Dec 2025 | 29.48 | 27.22 | 34.10B | 1.16B |
| Q3 FY2025 | 30 Sept 2025 | — | — | 32.27B | — |
| Q2 FY2025 | 30 Jun 2025 | — | — | 32.27B | — |
| Q1 FY2025 | 28 Mar 2025 | — | — | 32.79B | — |
| Q3 FY2024 | 30 Sept 2024 | — | — | 32.27B | — |
| Q2 FY2024 | 30 Jun 2024 | — | — | 32.27B | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.
See also:Market cap,P/S ratio,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Medline's P/E ratio
Source: Financial Modeling Prep